Based on the Compass Pathways Plc stock forecast from 2 analysts, the average analyst target price for Compass Pathways Plc is USD 23.00 over the next 12 months. Compass Pathways Plc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Compass Pathways Plc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Compass Pathways Plc’s stock price was USD 4.89. Compass Pathways Plc’s stock price has changed by -7.74% over the past week, -20.10% over the past month and -14.81% over the last year.
No recent analyst target price found for Compass Pathways Plc
No recent average analyst rating found for Compass Pathways Plc
Company Overview Compass Pathways Plc
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom. Read Less
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for th...Read More
Frequently Asked Questions About Compass Pathways Plc (CMPS) Stock
Based on ratings from 2 analysts Compass Pathways Plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on CMPS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for CMPS is USD 23.00 over the next 12 months. The maximum analyst target price is USD 23 while the minimum anlayst target price is USD 23.
Unfortunately we do not have enough data on CMPS's stock to indicate if its overvalued.
The last closing price of CMPS's stock was USD 4.89.
The most recent market capitalization for CMPS is USD 0.32B.
Based on targets from 2 analysts, the average taret price for CMPS is projected at USD 23.00 over the next 12 months.
This means that CMPS's stock price may go up by +370.35% over the next 12 months.
We can't find any ETFs which contains Compass Pathways Plc's stock.
As per our most recent records Compass Pathways Plc has 186 Employees.
Compass Pathways Plc's registered address is 33 Broadwick Street, London, United Kingdom, W1F 0DQ.
You can get more information about it from Compass Pathways Plc's website at https://compasspathways.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Compass Pathways Plc (CMPS) Stock
Based on ratings from 2 analysts Compass Pathways Plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on CMPS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for CMPS is USD 23.00 over the next 12 months. The maximum analyst target price is USD 23 while the minimum anlayst target price is USD 23.
Unfortunately we do not have enough data on CMPS's stock to indicate if its overvalued.
The last closing price of CMPS's stock was USD 4.89.
The most recent market capitalization for CMPS is USD 0.32B.
Based on targets from 2 analysts, the average taret price for CMPS is projected at USD 23.00 over the next 12 months.
This means that CMPS's stock price may go up by +370.35% over the next 12 months.
We can't find any ETFs which contains Compass Pathways Plc's stock.
As per our most recent records Compass Pathways Plc has 186 Employees.
Compass Pathways Plc's registered address is 33 Broadwick Street, London, United Kingdom, W1F 0DQ.
You can get more information about it from Compass Pathways Plc's website at https://compasspathways.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CMPS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
